PolyPeptide Group AG provided earnings guidance for the full year 2022. For the period, the company targets revenue growth of 12-14% versus 2021. The Group will continue to invest in modernizing and expanding its infrastructure with capital expenditures as % of 2022 revenue expected to be above 25%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.4 CHF | +3.89% | +4.54% | +90.64% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+90.64% | 1.22B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PPGN Stock
- News PolyPeptide Group AG
- PolyPeptide Group AG Provides Earnings Guidance for the Full Year 2022